The molecular mechanisms that control thrombopoiesis

被引:415
作者
Kaushansky, K [1 ]
机构
[1] Univ Calif San Diego, Dept Med, Div Hematol Oncol, San Diego, CA 92103 USA
关键词
D O I
10.1172/JCI26674
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Our understanding of thrombopoiesis - the formation of blood platelets - has improved greatly in the last decade, with the cloning and characterization of thrombopoietin, the primary regulator of this process. Thrombopoietin affects nearly all aspects of platelet production, from self-renewal and expansion of HSCs, through stimulation of the proliferation of megakaryocyte progenitor cells, to support of the maturation of these cells into platelet-producing cells. The molecular and cellular mechanisms through which thrombopoietin affects platelet production provide new insights into the interplay between intrinsic and extrinsic influences on hematopoiesis and highlight new opportunities to translate basic biology into clinical advances.
引用
收藏
页码:3339 / 3347
页数:9
相关论文
共 108 条
[1]  
ALEXANDER WS, 1995, ONCOGENE, V10, P795
[2]   Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis [J].
Avecilla, ST ;
Hattori, K ;
Heissig, B ;
Tejada, R ;
Liao, F ;
Shido, K ;
Jin, DK ;
Dias, S ;
Zhang, F ;
Hartman, TE ;
Hackett, NR ;
Crystal, RG ;
Witte, L ;
Hicklin, DJ ;
Bohlen, P ;
Eaton, D ;
Lyden, D ;
de Sauvage, F ;
Rafii, S .
NATURE MEDICINE, 2004, 10 (01) :64-71
[3]  
Axelrad AA, 2000, BLOOD, V96, P3310
[4]   Thrombopoietin is essential for the maintenance of normal Hematopoiesis in humans - Development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia [J].
Ballmaier, A ;
Germeshausen, M ;
Krukemeier, S ;
Welte, K .
HEMATOPOIETIC STEM CELLS 2002: GENETICS AND FUNCTION, 2003, 996 :17-25
[5]   c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia [J].
Ballmaier, M ;
Germeshausen, M ;
Schulze, H ;
Cherkaoui, K ;
Lang, S ;
Gaudig, A ;
Krukemeier, S ;
Eilers, M ;
Strauss, G ;
Welte, K .
BLOOD, 2001, 97 (01) :139-146
[6]   MACROPHAGES SPECIFICALLY REGULATE THE CONCENTRATION OF THEIR OWN GROWTH-FACTOR IN THE CIRCULATION [J].
BARTOCCI, A ;
MASTROGIANNIS, DS ;
MIGLIORATI, G ;
STOCKERT, RJ ;
WOLKOFF, AW ;
STANLEY, ER .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) :6179-6183
[7]   Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].
Baxter, EJ ;
Scott, LM ;
Campbell, PJ ;
East, C ;
Fourouclas, N ;
Swanton, S ;
Vassiliou, GS ;
Bench, AJ ;
Boyd, EM ;
Curtin, N ;
Scott, MA ;
Erber, WN ;
Green, AR .
LANCET, 2005, 365 (9464) :1054-1061
[8]   Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo) [J].
Bouscary, D ;
Lecoq-Lafon, C ;
Chrétien, S ;
Zompi, S ;
Fichelson, S ;
Muller, O ;
Porteu, F ;
Dusanter-Fourt, I ;
Gisselbrecht, S ;
Mayeux, P ;
Lacombe, C .
ONCOGENE, 2001, 20 (18) :2197-2204
[9]   Human platelets display high-affinity receptors for thrombopoietin [J].
Broudy, VC ;
Lin, NL ;
Sabath, DF .
BLOOD, 1997, 89 (06) :1896-1904
[10]   THROMBOPOIETIN (C-MPL LIGAND) ACTS SYNERGISTICALLY WITH ERYTHROPOIETIN, STEM-CELL FACTOR, AND INTERLEUKIN-11 TO ENHANCE MURINE MEGAKARYOCYTE COLONY GROWTH AND INCREASES MEGAKARYOCYTE PLOIDY IN-VITRO [J].
BROUDY, VC ;
LIN, NL ;
KAUSHANSKY, K .
BLOOD, 1995, 85 (07) :1719-1726